Abstract:COVID-19 pandemic began in Wuhan, China, in December 2019. Almost 80% of the patients are asymptomatic or mildly symptomatic. About 15% require hospitalization and 5% need intensive care unit (ICU) admission. Cytokine release syndrome (CRS) is a life-threatening illness which has shown promising result with the use of tocilizumab. This case reports the importance of early recognition and appropriate management of this life-threatening illness.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.